To further solidify this similarity, we plot the progression free survival (PFS), or the length of time during the treatment where the tumor does not progress, of the Pb-Tx vs. original anti-PD-L1 therapy in Fig. 3c. The gene discussed is CD274; the disease is neoplasm.